《中国成人艰难梭菌感染诊断和治疗专家共识》解读
DOI:
作者:
作者单位:

作者简介:

通讯作者:

基金项目:

国家自然科学基金


Interpretation of Expert Consensus on the Diagnosis and Treatment of Clostridium Difficile Infection in Adults
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
    摘要:

    【摘要】艰难梭菌(Clostridium difficile,CD)为人类肠道的条件致病菌,是医院和社区感染性腹泻的重要病原菌。随着抗生素的滥用及高毒力菌株027/NAP1/BI型的流行,艰难梭菌感染(CDI)的发病率不断上升,已引起世界范围的关注。2017年发表的《中国成人艰难梭菌感染诊断和治疗专家共识》是首次针对CDI诊断和治疗的中国专家共识,在业界受到高度关注。本文就《中国成人艰难梭菌感染诊断和治疗专家共识》中艰难梭菌感染的诊断、检测及治疗进行解读。

    Abstract:

    【Abstract】 Clostridium difficile (CD) is a conditional pathogen of human intestinal tract, which is an important pathogen of infectious diarrhea in hospitals and communities. With the abuse of antibiotics and the prevalence of high virulent strain 027 / Nap1 / Bi, the incidence of Clostridium difficile infection (CDI) is increasing, which has attracted worldwide attention. The Expert Consensus on the Diagnosis and Treatment of Adult Clostridium Difficile Infection published in 2017 is the first Chinese Expert Consensus on the Diagnosis and Treatment of CDI, which has attracted great attention. In this paper, the diagnosis, detection and treatment of C. difficile infection in the "Consensus of Experts on the Diagnosis and Treatment of C. difficile infection in Chinese Adults" were interpreted.

    参考文献
    相似文献
    引证文献
引用本文
分享
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2020-02-13
您是第位访问者
网站版权所有:《西部医学》编辑部     蜀ICP备18038379号-4
地址:四川省成都市武侯区小天竺街75号财富国际18F-1号    邮政编码:610041
电话:028-85570072/85588403 本网站支持 IPv6    E-mail:xbyxqk@163.com
技术支持:北京勤云科技发展有限公司